BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 29145693)

  • 1. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004863. PubMed ID: 29145693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD004863. PubMed ID: 32048730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD004868. PubMed ID: 30776084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004868. PubMed ID: 31990982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004863. PubMed ID: 24771408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher S; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004868. PubMed ID: 16856064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004868. PubMed ID: 22972077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD004865. PubMed ID: 32048729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2012 Oct; 10():CD004865. PubMed ID: 23076909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol in preterm infants at risk for or having respiratory distress syndrome.
    Howlett A; Ohlsson A; Plakkal N
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003481. PubMed ID: 30264852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
    Mitra S; Scrivens A; von Kursell AM; Disher T
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.